This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Icahn School of Medicine at Mount Sinai, University of California. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 536 
2 out of 16,008 
Years Active: 2016-2018
Title: Tirtha K Das: Innovator in Cancer Treatment
Introduction
Tirtha K Das is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of cancers. With a total of 2 patents, his work is recognized for its potential impact on medical science.
Latest Patents
Among his latest patents are the novel therapeutic compounds titled "Substituted pyrazolo[3,4-D]pyrimidines and uses thereof." These patents present innovative methods for using these compounds in the treatment of various cancers. The focus on developing effective cancer treatments highlights his commitment to advancing medical research.
Career Highlights
Tirtha K Das has worked with esteemed institutions such as the University of California and the Icahn School of Medicine at Mount Sinai. His experience in these reputable organizations has allowed him to collaborate with leading experts in the field, further enhancing his research capabilities.
Collaborations
Some of his notable coworkers include Arvin C Dar and Martin Sos. Their collaboration has contributed to the advancement of research in therapeutic compounds and cancer treatment.
Conclusion
Tirtha K Das is a dedicated inventor whose work in developing therapeutic compounds for cancer treatment is noteworthy. His contributions to the field are expected to have a lasting impact on medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile